41970EGP
- Active ingredient
- lenvatinib
- Strength
- 10 mg
- Form
- capsule
- Manufacturer
- eisai > multipharma
- Route
- oral.solid
Uses
Used for selected advanced cancers including differentiated thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, and certain endometrial cancers.
Do not use if
No specific contraindications are listed in the prescribing information, but hypersensitivity requires discontinuation.
Side effects
Common adverse effects include hypertension, fatigue, diarrhea, decreased appetite, proteinuria, and weight loss.
Warnings
Monitor blood pressure, cardiac function, liver function, and renal function during treatment.
How it works
Multi-kinase inhibitor that blocks VEGF receptors and other pathways involved in tumor growth and angiogenesis.
Storage
Store at room temperature in the original package and protect from moisture.
